Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ERN1 | O75460 | 8/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7596265 | 0.88 | KMT2A (0.48) | KMT2AERN1CDK1CA2ALDH1A1 | |
| SCHEMBL21511206 | 0.82 | HDAC6 (0.45) | KMT2AERN1LMNA | |
| SCHEMBL21658544 | 0.81 | HDAC6 (0.47) | KMT2AERN1CDK1 | |
| SCHEMBL21658541 | 0.81 | HDAC6 (0.47) | KMT2AERN1CDK1 | |
| SCHEMBL21658542 | 0.81 | ESR1 (0.45) | KMT2AERN1LMNA | |
| SCHEMBL27754195 | 0.79 | KMT2A (0.60) | KMT2AHPGDALDH1A1LMNAMAPT | |
| SCHEMBL6665857 | 0.78 | ERN1 (0.60) | KMT2AERN1CDK1TRIM24TYR | |
| SCHEMBL21306617 | 0.78 | ERN1 (0.56) | KMT2AERN1CDK1TRIM24TYR | |
| SCHEMBL21658630 | 0.77 | ERN1 (0.46) | KMT2AERN1CA2 | |
| SCHEMBL11122329 | 0.77 | KMT2A (0.65) | KMT2AHPGDALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160200841-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICAL ANISOTROPIC BODY | ZEON CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| EP-3037444-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICAL ANISOTROPIC BODY | Zeon Corporation (JP) | 2016-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200841-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICAL ANISOTROPIC BODY | F12, PYM1, C5 | KMT2A 1583/4885ERN1 1984/4885CDK1 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.